Sanofi Takes Aim at Dengue Fever - Presented by: The Aol. On Network

It's the fastest-growing tropical disease, killing an estimated 20,000 people a year. Nearly half the world's population is at risk of contracting dengue fever. 100 million people each year are infected according to the World Health Organisation. France's Sanofi has been developing a dengue vaccine for the past 20 years. Now a large clinical study in five Asian countries showed the three-dose vaccine provides moderate protection against the disease.



Related Videos

Most Popular Videos

Latest Videos


Most Active by Volume

Company Last Sale Change Net / %
HCA $ 73 4.36 ▲ 6.35%
BAC $ 15.85 0.12 ▲ 0.76%
AAPL $ 113.10 0.12 ▲ 0.11%
OCN $ 6.91 0.56 ▲ 8.82%
GE $ 24.59 0.11 ▲ 0.45%
MSFT $ 47.01 0.17 ▼ 0.36%
SIRI $ 3.66 0.09 ▲ 2.52%
SWY $ 35.10 0.19 ▼ 0.54%

As of 1/26/2015, 04:06 PM
More Most Active